Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice

Endocrine

Volumn 46, Issue 3, 2014, Pages 462-469

  Kim, Junghyun ^a   Kim, Chan Sik ^a   Lee, Ik Soo ^a   Lee, Yun Mi ^a   Sohn, Eunjin ^a   Jo, Kyuhyung ^a   Kim, Joo Hwan ^b   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Gachon University   (South Korea)

Author keywords

Blood retinal barrier; Diabetic retinopathy; Litsea japonica; Occludin; Vascular endothelial growth factor

Indexed keywords

ALCOHOL; EPICATECHIN; FLAVONOID; KAEMPFEROL 3 RHAMNOSIDE; LITSEA JAPONICA EXTRACT; OCCLUDIN; PLANT EXTRACT; QUERCITRIN; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; CONTROLLED STUDY; DB DB MOUSE; DIABETIC RETINOPATHY; HYPERGLYCEMIA; MALE; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RETINA DISEASE; RETINAL VASCULAR LEAKAGE; TREATMENT DURATION; ANIMAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; LITSEA; METABOLISM; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; BLOOD-RETINAL BARRIER; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; LITSEA; MICE; OCCLUDIN; PLANT EXTRACTS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904562047     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0085-x     Document Type: Article

References (38)

1. J. Cunha-Vaz, R. Bernardes, Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes. Prog. Retin. Eye Res. 24, 355-377 (2005)
2. S. Roy, T. Sato, G. Paryani, R. Kao, Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 52, 1229-1234 (2003)
3. J.P. De La Cruz, J.A. Gonzalez-Correa, A. Guerrero, F.S. de la Cuesta, Pharmacological approach to diabetic retinopathy. Diabetes Metab. Res. Rev. 20, 91-113 (2004)
4. S.E. Moss, R. Klein, B.E. Klein, The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105, 998-1003 (1998)
5. R. Klein, B.E. Klein, S.E. Moss, M.D. Davis, D.L. DeMets, The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 91, 1464-1474 (1984)
6. C. Kaur, W.S. Foulds, E.A. Ling, Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog. Retin. Eye Res. 27, 622-647 (2008)
7. D. Mehta, A.B. Malik, Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367 (2006)
8. N.S. Harhaj, D.A. Antonetti, Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 36, 1206-1237 (2004)
9. A.J. Barber, A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 283-290 (2003)
10. F.J. Alarcon-Aguilara, R. Roman-Ramos, S. Perez-Gutierrez, A. Aguilar-Contreras, C.C. Contreras-Weber, J.L. Flores-Saenz, Study of the anti-hyperglycemic effect of plants used as antidiabetics. J. Ethnopharmacol. 61, 101-110 (1998)
11. W.L. Li, H.C. Zheng, J. Bukuru, N. De Kimpe, Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 92, 1-21 (2004)
12. S.Y. Lee, B.S. Min, J.H. Kim, J. Lee, T.J. Kim, C.S. Kim, Y.H. Kim, H.K. Lee, Flavonoids from the leaves of Litsea japonica and their anti-complement activity. Phytother. Res. 19, 273-276 (2005)
13. B.S. Min, S.Y. Lee, J.H. Kim, O.K. Kwon, B.Y. Park, R.B. An, J.K. Lee, H.I. Moon, T.J. Kim, Y.H. Kim, H. Joung, H.K. Lee, Lactones from the leaves of Litsea japonica and their anti-complement activity. J. Nat. Prod. 66, 1388-1390 (2003)
14. S.J. Wang, Y. Tong, S. Lu, R. Yang, X. Liao, Y.F. Xu, X. Li, Anti-inflammatory activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves. Planta Med. 76, 1492-1496 (2010)
15. D. Mantle, F. Eddeb, A.T. Pickering, Comparison of relative antioxidant activities of British medicinal plant species in vitro. J. Ethnopharmacol. 72, 47-51 (2000)
16. D.G. Kang, C. Yun, H.S. Lee, Screening and comparison of antioxidant activity of solvent extracts of herbal medicines used in Korea. J. Ethnopharmacol. 87, 231-236 (2003)
17. A.N. Witmer, G.F. Vrensen, C.J. Van Noorden, R.O. Schlingemann, Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye. Res. 22, 1-29 (2003)
18. T. Murata, T. Ishibashi, A. Khalil, Y. Hata, H. Yoshikawa, H. Inomata, Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res. 27, 48-52 (1995)
19. S.A. Vinores, A.I. Youssri, J.D. Luna, Y.S. Chen, S. Bhargave, M.A. Vinores, C.L. Schoenfeld, B. Peng, C.C. Chan, W. LaRochelle, W.R. Green, P.A. Campochiaro, Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol. Histopathol. 12, 99-109 (1997)
20. I. Suzuma, Y. Hata, A. Clermont, F. Pokras, S.L. Rook, K. Suzuma, E.P. Feener, L.P. Aiello, Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 50, 444-454 (2001)
21. E.C. Tsilibary, Microvascular basement membranes in diabetes mellitus. J. Pathol. 200, 537-546 (2003)
22. T.N. Crawford, D.V. Alfaro 3rd, J.B. Kerrison, E.P. Jablon, Diabetic retinopathy and angiogenesis. Curr. Diabetes Rev. 5, 8-13 (2009)
23. D.Y. Yu, S.J. Cringle, E.N. Su, P.K. Yu, G. Jerums, M.E. Cooper, Pathogenesis and intervention strategies in diabetic retinopathy. Clin. Experiment. Ophthalmol. 29, 164-166 (2001)
24. D.A. Antonetti, A.J. Barber, S. Khin, E. Lieth, J.M. Tarbell, T.W. Gardner, Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47, 1953-1959 (1998)
25. M. Furuse, T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura, S. Tsukita, Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123, 1777-1788 (1993)
26. P.M. Watson, J.M. Anderson, C.M. Vanltallie, S.R. Doctrow, The tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriers. Neurosci. Lett. 129, 6-10 (1991)
27. T. Hirase, J.M. Staddon, M. Saitou, Y. Ando-Akatsuka, M. Itoh, M. Furuse, K. Fujimoto, S. Tsukita, L.L. Rubin, Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110, 1603-1613 (1997)
28. C. Campa, S.P. Harding, Anti-VEGF compounds in the treatment of neovascular age related macular degeneration. Curr. Drug Targets 12, 173-181 (2011)
29. E. Chen, J. Hsu, C.H. Park, Acute visual acuity loss following intravitreal bevacizumab for diabetic macular edema. Ophthalmic. Surg. Lasers Imaging 40, 68-70 (2009)
30. S.C. Costa, P.A. Girard, M. Brehelin, R. Zumbihl, The emerging human pathogen Photorhabdus asymbiotica is a facultative intracellular bacterium and induces apoptosis of macrophage-like cells. Infect. Immun. 77, 1022-1030 (2009)
31. M. Bimakr, R.L.A. Rahman, F.S. Taip, A. Ganjloo, L.M. Salleh, J. Selamat, A. Hamid, I.S.M. Zaidul, Comparison of different extraction methods for the extraction of major bioactive flavonoid compounds from spearmint (Mentha spicata L.) leaves. Food Bioprod. Process. 89, 67-72 (2011)
32. L. Fan, Y. Zhang, R. Huang, S. Qin, T. Yi, F. Xu, Y. Tang, X. Qu, H. Chen, J. Miao, Determination of five flavonoids in different parts of Fordia cauliflora by ultra performance liquid chromatography/triple-quadrupole mass spectrometry and chemical comparison with the root of Millettia pulchra var. laxior. Chem. Cent. J. 7, 126 (2013)
33. T. Suzuki, H. Hara, Role of flavonoids in intestinal tight junction regulation. J. Nutr. Biochem. 22, 401-408 (2011)
34. A.M. Robert, J.M. Tixier, L. Robert, J.M. Legeais, G. Renard, Effect of procyanidolic oligomers on the permeability of the blood-brain barrier. Pathol. Biol. 49, 298-304 (2001)
35. K. Taguchi, Y. Hagiwara, K. Kajiyama, Y. Suzuki, Pharmacological studies of Houttuyniae herba: the anti-inflammatory effect of quercitrin. Yakugaku Zasshi 113, 327-333 (1993)
36. T. Yokozawa, E. Dong, Y. Kawai, M. Gemba, M. Shimizu, Protective effects of some flavonoids on the renal cellular membrane. Exp. Toxicol. Pathol. 51, 9-14 (1999)
37. S. Noda, S. Tanabe, T. Suzuki, Differential effects of flavonoids on barrier integrity in human intestinal Caco-2 cells. J. Agric. Food Chem. 60, 4628-4633 (2012)
38. V. Poulaki, W. Qin, A.M. Joussen, P. Hurlbut, S.J. Wiegand, J. Rudge, G.D. Yancopoulos, A.P. Adamis, Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J. Clin. Invest. 109, 805-815 (2002)